Eiger BioPharmaceuticals, Inc. License Agreements
13 Contracts & Agreements
- Amendment No. 7 to License Agreement, dated November 3, 2020, by and between Eiger BioPharmaceuticals, Inc. and Merck Sharp & Dohme Corp (Filed With SEC on March 9, 2021)
- Amendment No. 6 to License Agreement, dated September 3, 2010, by and between Eiger BioPharmaceuticals, Inc. and Merck Sharp & Dohme Corp (Filed With SEC on March 9, 2021)
- License Agreement, dated as of April 20, 2016, by and between Eiger BioPharmaceuticals, Inc. and Bristol-Myers Squibb Company (Filed With SEC on March 9, 2021)
- License Agreement, dated September 3, 2010, by and between Eiger BioPharmaceuticals, Inc. and Merck Corporation (Filed With SEC on March 9, 2021)
- License Agreement, dated as of May 10, 2019, by and among the Trustees of the University of Pennsylvania and The Childrens Hospital of Philadelphia and Eiger Biopharmaceuticals,... (Filed With SEC on November 7, 2019)
- Amendment No. 6 to License Agreement, dated September 2, 2010, by and between Eiger BioPharmaceuticals, Inc. and Merck Sharp & Dohme Corp (Filed With SEC on August 10, 2018)
- LICENSE AGREEMENT (Filed With SEC on December 14, 2015)
- LICENSE AGREEMENT (Filed With SEC on December 14, 2015)
- LICENSE AGREEMENT (Filed With SEC on December 14, 2015)
- AMENDED ANDRESTATED LICENSE AGREEMENT (Filed With SEC on October 11, 2013)
- NON-EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on October 11, 2013)
- UNIVERSITY OF MINNESOTA EXCLUSIVE PATENT LICENSE AGREEMENT (Filed With SEC on October 11, 2013)
- NON-EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on October 11, 2013)
